Theravance Biopharma
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for t...
Latest News
10 months ago · zacks.com
Is the Options Market Predicting a Spike in Theravance Biopharma Stock?Investors need to pay close attention to TBPH stock based on the movements in the options market lately.
10 months ago · zacks.com
Why Theravance Biopharma (TBPH) is a Top Momentum Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
10 months ago · zacks.com
Why Theravance Biopharma (TBPH) is a Top Growth Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove TBPH